Literature DB >> 16307489

The glutamatergic system outside the CNS and in cancer biology.

Niki Kalariti1, Nikos Pissimissis, Michael Koutsilieris.   

Abstract

Glutamate is a major excitatory neurotransmitter in the CNS. The signalling machinery consists of: glutamate receptors, which are responsible for signal input; plasma glutamate transporters, which are responsible for signal termination; and vesicular glutamate transporters for signal output through exocytic release. Recently, data have suggested that the glutamatergic system plays an important role in non-neuronal tissues. In addition, the expression of glutamatergic system has been implicated in tumour biology. This review outlines the evidence, which suggests that the glutamatergic system may have an important role in cancer biology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16307489     DOI: 10.1517/13543784.14.12.1487

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN: 1354-3784            Impact factor:   6.206


  27 in total

1.  Glutamate Transporters: Expression and Function in Oligodendrocytes.

Authors:  Edna Suárez-Pozos; Elizabeth J Thomason; Babette Fuss
Journal:  Neurochem Res       Date:  2019-01-09       Impact factor: 3.996

2.  Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profiling.

Authors:  Mark E McDonnell; Matthew D Vera; Benjamin E Blass; Jeffrey C Pelletier; Richard C King; Carmen Fernandez-Metzler; Garry R Smith; Jay Wrobel; Suzie Chen; Brian A Wall; Allen B Reitz
Journal:  Bioorg Med Chem       Date:  2012-07-21       Impact factor: 3.641

Review 3.  Tumor progression: the neuronal input.

Authors:  Marco Arese; Federico Bussolino; Margherita Pergolizzi; Laura Bizzozero; Davide Pascal
Journal:  Ann Transl Med       Date:  2018-03

4.  Expression of the metabotropic glutamate receptor 5 (mGluR5) induces melanoma in transgenic mice.

Authors:  Kyu Yeong Choi; Kai Chang; James M Pickel; John D Badger; Katherine W Roche
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

5.  Dipeptide Prodrugs of the Glutamate Modulator Riluzole.

Authors:  Jeffrey C Pelletier; Suzie Chen; Haiyan Bian; Raj Shah; Garry R Smith; Jay E Wrobel; Allen B Reitz
Journal:  ACS Med Chem Lett       Date:  2018-06-15       Impact factor: 4.345

Review 6.  The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells.

Authors:  Yonatan Ganor; Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-03-02       Impact factor: 3.575

7.  Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.

Authors:  Mohanan Valiya Veettil; Gayathri Krishna; Arunava Roy; Anandita Ghosh; Dipanjan Dutta; Binod Kumar; Sayan Chakraborty; Thoppil Raveendran Anju; Neelam Sharma-Walia; Bala Chandran
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

Review 8.  Metabotropic glutamate receptors (mGlus) and cellular transformation.

Authors:  Seung-Shick Shin; Jeffrey J Martino; Suzie Chen
Journal:  Neuropharmacology       Date:  2008-05-07       Impact factor: 5.250

9.  Expression of glutamate receptor subunits in human cancers.

Authors:  Andrzej Stepulak; Hella Luksch; Christine Gebhardt; Ortrud Uckermann; Jenny Marzahn; Marco Sifringer; Wojciech Rzeski; Christian Staufner; Katja S Brocke; Lechoslaw Turski; Chrysanthy Ikonomidou
Journal:  Histochem Cell Biol       Date:  2009-06-14       Impact factor: 4.304

10.  VGluT2 expression in painful Achilles and patellar tendinosis: evidence of local glutamate release by tenocytes.

Authors:  Alexander Scott; Håkan Alfredson; Sture Forsgren
Journal:  J Orthop Res       Date:  2008-05       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.